UASK 2023 SCIENTIFIC PROGRAM
  • Is Remission Possible in Severe Asthma? Phenotypic Approach
  • Lung Cancer Case Council
  • Immunotherapy in Lung Cancer and Mesothelioma
  • Genetic Tests and Liquid Biopsy in Lung Cancer
  • Salvage Surgery in Lung Cancer
  • Role of Bronchoscopy in Diagnosis, Staging and Treatment of Lung Cancers
  • Volume Reduction Interventions in Emphysema Patients
  • Anti TNF Drugs and Tuberculosis Risk Management
  • Innovations in Diagnostic Algorithm of Asthma
  • Self-Management Strategy in Asthma Treatment
  • Biological Agents in Asthma: To Whom? When? Which Biological Agent Should Be Preferred?
  • Diagnosis-Treatment Management of Atypical Mycobacteria
  • Antibiotic Treatment, Mucoactive Treatment and Rehabilitation in Bronchiectasis
  • Interventional Pulmonology on Alive Cases
  • Long-Term Effects of COVID-19 “Long Covid”
  • EBUS Case Presentations
  • What's New in the ESC/ERS 2022 Pulmonary Arterial Hypertension Guidelines?
  • Pulmonary Rehabilitation: At Home? Or In the Hospital?
  • What's New in the GINA 2023 Guide?
  • What Has Changed in the GOLD 2023 COPD Guidelines?
  • Enhanced Recovery After Surgery(ERAS) Protocol in Thoracic Surgery
  • Chest Diseases Disability Assessment
  • Digital Health in Chest Diseases
  • Telemedicine in Chest Diseases: Video-Polyclinic Examples from the World and Turke
  • Choosing the Appropriate Treatment in Mild or Severe Asthma
  • New Terms in Our Lives; What is: Artificial Intelligence? Machine Learning? Deep Learning?
  • Physicians learning about their legal rights
  • What Should I Do When Heparin Induced Thrombocytopenia (HIT) Develops or Pulmonary Embolism is Detected in a Thrombocytopenic Patient?
  • Evaluation of Interstitial Lung Diseases: Surgical Lung Biopsy or Cryo Transbronchial Bronchial Biopsy?
  • Coexistence of Interstitial Pulmonary Fibrosis with Lung Cancer
  • Which Drug Should I Choose When Pulmonary Embolism Is Detected in a Patient Who is Diagnosed with Cancer?
  • Recent Advances in New Targeted Therapies in NSCLC
  • Management of Infections in Cystic Fibrosis
  • Clinical Case Discussions: Situations Confused with Asthma
  • Is COPD Epidemiology Changing?
  • Nutrition in COPD Patients
  • What Should Our Mechanical Ventilator Strategy Be in COPD and Adults Respiratory Distress Syndorme (ARDS) Patients?
  • Pulmonary Telerehabilitation in COPD
  • Management of COPD Patients with Frequent Exacerbations
  • How Should Individual-Specific Treatment Be Planned in COPD?
  • Early Treatment in COPD Changes the Course of the Disease:  It Does / It Doesn't.
  • Interventional Bronchoscopic Treatments in COPD
  • Management of Uncontrolled Dyspnea in COPD
  • Markers of Mortality and Advanced Care Planning in COPD
  • Combined Pulmonary Fibrosis Emphysema
  • Management of Chronic Cough
  • Locally Advanced Non-Small Cell Lung Cancers
  • Management of Malignant Pleural Effusion
  • Occupational Lung Diseases
  • Our Personal Rights
  • Compliance with Positive Airway Pressure (PAP) Treatment
  • Pleural Effusions and Thoracic USG
  • Current Approach to Post Intubation Tracheal Stenoses
  • Antifibrotic Treatment in Progressive Pulmonary Fibrosis
  • When Should I End Pulmonary Embolism Treatment?
  • Case Discussion on Radiology
  • Management of Refractory Sarcoidosis Treatment
  • Advances in Robotic Surgery
  • Lung Involvement in Rheumatological Diseases: Update on Treatment Algorithm
  • Surgery in T4 Tumors
  • Palliative Care in Terminal Stage COPD
  • Management of Community Acquired Pneumonia
  • Current Advances in Tuberculosis Treatment
  • Personalized Treatment in Sleep Disorders
  • New Treatment Methods in Sleep Disorders
  • Pulmonary Rehabilitation in Long-Covid (Status in Turkey and in the World)
  • Case Council on VATS Complications
  • Changes in the New IPF Guidelines
  • The New Malpractice Law and What It Brings
  • How to Treat Infection in Intensive Care Patients?
  • Ultrasonography, Echocardiography, Bronchoscopy in Intensive Care
  • Bronchoscopy in Challenging Cases